Emergent BioSolutions Inc (EBS)
9.27
-0.70
(-7.02%)
USD |
NYSE |
Nov 14, 16:00
9.17
-0.10
(-1.08%)
After-Hours: 20:00
Emergent BioSolutions Gross Profit (Annual): 317.60M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 317.60M |
| December 31, 2022 | 383.00M |
| December 31, 2021 | 891.30M |
| December 31, 2020 | 925.20M |
| December 31, 2019 | 550.00M |
| December 31, 2018 | 383.10M |
| December 31, 2017 | 302.70M |
| December 31, 2016 | 219.10M |
| December 31, 2015 | 264.45M |
| December 31, 2014 | 210.83M |
| December 31, 2013 | 195.80M |
| Date | Value |
|---|---|
| December 31, 2012 | 169.80M |
| December 31, 2011 | 160.24M |
| December 31, 2010 | 204.27M |
| December 31, 2009 | 188.52M |
| December 31, 2008 | 144.47M |
| December 31, 2007 | 142.61M |
| December 31, 2006 | 128.61M |
| December 31, 2005 | 99.08M |
| December 31, 2004 | 53.39M |
| December 31, 2003 | |
| December 31, 2002 | 53.97M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
317.60M
Minimum
2023
925.20M
Maximum
2020
613.42M
Average
550.00M
Median
2019
Gross Profit (Annual) Benchmarks
| Geovax Labs Inc | -- |
| Tonix Pharmaceuticals Holding Corp | 3.027M |
| Abbott Laboratories | 22.13B |
| SIGA Technologies Inc | 105.66M |
| Chimerix Inc | 0.324M |